Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction
Open Access
- 7 August 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (32), 13104-13109
- https://doi.org/10.1073/pnas.0702778104
Abstract
Previous studies have documented that 0.1≈1% of input recombinant adeno-associated virus (rAAV) vectors could be stabilized and lead to transgene expression. To characterize the steps involving massive AAV DNA loss, we designed an“AAV footprinting” strategy that can track newly formed AAV dsDNA genomes. This strategy is based on an ROSA26R mouse model or cell line that carries a lacZ gene flanked by two loxP sites. When it is transduced by a rAAV vector carrying the Cre recombinase, the lacZ gene can be activated and remain active even when rAAV genomes are later lost. By using this sensitive AAV footprinting technique, we confirmed the existence of transient AAV dsDNA that went undetected by conventional DNA methods. Although these dsDNA intermediates could be efficiently formed in almost every cell and were competent for mRNA transcription and protein synthesis in vivo, they got lost continuously. Only a small fraction was eventually stabilized for sustained gene expression. Although both rAAV2 and rAAV8 can potentially have similar levels of dsDNA formation, AAV8 dsDNA was formed much faster than that of AAV2, which explains why rAAV8 is more efficient than rAAV2 in transducing the liver. Collectively, our studies suggested that rather than receptor binding, viral entry, and ssDNA to dsDNA conversion, the instability of newly formed AAV dsDNA was the primary contributing factor for the low rAAV transduction efficacy. The uncoating step significantly influenced the stability of AAV transient dsDNA. The identification of transient AAV dsDNA provided a new pathway for improving rAAV transduction.Keywords
This publication has 62 references indexed in Scilit:
- Self-Complementary Recombinant Adeno-Associated Viral Vectors: Packaging Capacity And The Role of Rep Proteins in Vector PurityHuman Gene Therapy, 2007
- Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4Journal of Virology, 2006
- Host Cell DNA Repair Pathways in Adeno-Associated Viral Genome ProcessingJournal of Virology, 2006
- Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectorsVirology, 2006
- rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashionMolecular Therapy, 2006
- Efficient AAV1–AAV2 Hybrid Vector for Gene Therapy of HemophiliaHuman Gene Therapy, 2006
- Intracellular Viral Processing, Not Single-Stranded DNA Accumulation, Is Crucial for Recombinant Adeno-Associated Virus TransductionJournal of Virology, 2004
- Clinical Gene Transfer Studies for Hemophilia BSeminars in Thrombosis and Hemostasis, 2004
- Adeno-Associated Virus Type 2-Mediated Gene Transfer: Altered Endocytic Processing Enhances Transduction Efficiency in Murine FibroblastsJournal of Virology, 2001
- Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome DegradationJournal of Virology, 2001